2nd Quarter - Report

TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC

Firm
Client
Income
—
Expenses
$315,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Importation issues; Preserve Access to Affordable Generics Act; S. 319 Pharmaceutical Market Access and Drug Safety Act;

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE; Treasury, Dept of; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Bills named: S. 319 (112th)

Copyright/Patent/Trademark CPT

S. 23 Patent Reform Act of 2011; S. 27 Preserve Access to Affordable Generics; general patent settlement issues; HR 1249, America Invents Act; S. 968, the PROTECT IP Act

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Treasury, Dept of; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD)

Bills named: S. 968 (112th), S. 27 (112th), S. 23 (112th), H.R. 1249 (112th)

Medical/Disease Research/Clinical Labs MED

Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239)

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 2239 (112th)

Manufacturing MAN

Prescription Drug User Fee Act Reauthorization; FDA Sentinel Pilot; S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R.2245, Preserving Access to Life-Saving Medications Act of 2011; DTC advertising; HR 1483 Drug Import Ssafety legislation;

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); SENATE; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 319 (112th), H.R. 1483 (112th), H.R. 2245 (112th)

Taxation/Internal Revenue Code TAX

Implementaton of ACA Pharmaceutical fee; corporate tax reform, R&D tax credit extension; Debt commissions recommendations; Reid/Baucus Lundgren repeal of Patient Protection and Affordable Care Act; Innovate America Act; Ryan Roadmap; Debt and deficit negotiations; foreign tax reforms; HR. 2190/S.1206 Medicare Drug Savings Act of 2011

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Defense, Dept of (DOD); Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: S. 1206 (112th), H.R. 2190 (112th)

Health Issues HCR

General comparative effectiveness issues, health reform and the un/underinsured, chronic disease legislation (diabetes, mental health, obesity, CKD), value based insurance design, quality of care, adhereance, ACA implementation; Anit-Gout USP matters; PCORI; Essential benefits package, ESRD bundling implementation; coverage gap, S. 371/HR741 Bill to prohibit authorized generics, Debt and Deficit negotiations HR 2, Repealing the Job-Killing Health Care Law ; Office of Consumer Information and Insurance Oversight; Essential Benefits Committee; Comparative Effectiveness; Patient Centered Outcomes Research Institute; S. 668 The Health Care Bureaucrats Elimination Act;

LobbyistCovered position, as disclosed
LAURA ELIZABETH CLINE —
DEBORAH LYNN WALTER —
ANDREA WILKINSON —

Contacted: Treasury, Dept of; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES

Bills named: S. 668 (112th), H.R. 741 (112th), H.R. 2 (112th), S. 371 (112th)

Medicare/Medicaid MMM

340B-1 and AMP, Part D coverage gap discount program implelmentation, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform; Value based Purchasing Program; End Stage Renal Disease final rules; TRICARE, HR 457 Medicare Decisions Accountability Act of 2011 (IPAB repeal), Medicare Evident Development and Coverage Ad Com.; Medicare Payment Advisory Commission; S. 31 Prescription Drug and Health Improvement Act; Debt and deficit negotiations S. 44 Medicare Prescription Drug Price Negotiation Act; CMS proposed Medicare Advantage; S 373 Fair Prescription Drug Competition Act; Ryan Roadmap; HR. 2190/S.1206 Medicare Drug Savings Act of 2011; the Medicaid Improvement and State Empowerment Act

LobbyistCovered position, as disclosed
LAURA ELIZABETH CLINE —
DEBORAH LYNN WALTER —
ANDREA WILKINSON —

Contacted: SENATE; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Treasury, Dept of; Defense, Dept of (DOD)

Bills named: S. 1206 (112th), S. 44 (112th), H.R. 457 (112th), H.R. 2190 (112th), S. 31 (112th)

Budget/Appropriations BUD

Agriculture; Labor, HHS; Commerce and Homeland Security Departments Appropriation Bills

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Treasury, Dept of; Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.